• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Neuroscience
  • A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo

Disease
Clinical Neuroscience
Drug Name
AZD2423
Generic Name
AZD2423
Sponsor
AstraZeneca
Drug Status
In Development
Phase
II
Start Date
Jan 18, 1971
Study Name
D2600C00005
Study Id
D2600C00005
ClinicalTrials.gov ID
NCT01201317
Recruiting Status
Closed
Protocol Status
Not Available
Report Status
Not Available

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013